HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jonas Lundahl Selected Research

gaboxadol (THIP)

8/2012EEG spectral power density profiles during NREM sleep for gaboxadol and zolpidem in patients with primary insomnia.
8/2009A 2-week efficacy and safety study of gaboxadol and zolpidem using electronic diaries in primary insomnia outpatients.
5/2007The selective extrasynaptic GABAA agonist, gaboxadol, improves traditional hypnotic efficacy measures and enhances slow wave activity in a model of transient insomnia.
3/2007Effect of short-term treatment with gaboxadol on sleep maintenance and initiation in patients with primary insomnia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jonas Lundahl Research Topics

Disease

4Sleep Initiation and Maintenance Disorders (Insomnia)
08/2012 - 03/2007
1Substance Withdrawal Syndrome (Withdrawal Symptoms)
08/2009

Drug/Important Bio-Agent (IBA)

4gaboxadol (THIP)IBA
08/2012 - 03/2007
3Zolpidem (Ambien)FDA LinkGeneric
08/2012 - 05/2007
1gamma-Aminobutyric Acid (GABA)IBA
08/2009
1Hypnotics and Sedatives (Sedatives)IBA
05/2007